Literature DB >> 18242062

The novel tellurium immunomodulator AS101 inhibits interleukin-10 production and p38 MAPK expression in atopic dermatitis.

Dvora Sredni-Kenigsbuch, Michael Shohat, Batia Shohat, Dan Ben-Amitai, Chi-Chao Chan, Michael David.   

Abstract

The immunomodulator, AS101, inhibits production of IL-10, IL-4 and expression of p38 MAPK, while increasing production of IFNgamma and IL-2. Together with its excellent clinical safety profile in humans, suggests a potential therapeutic use for AD.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18242062     DOI： 10.1016/j.jdermsci.2007.12.007

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


  5 in total

1.  A novel organotellurium compound (RT-01) as a new antileishmanial agent.

Authors:  Camila Bárbara Cantalupo Lima; Wagner Welber Arrais-Silva; Rodrigo Luiz Oliveira Rodrigues Cunha; Selma Giorgio
Journal:  Korean J Parasitol       Date:  2009-08-28       Impact factor: 1.341

2.  Novel microwave-assisted synthesis of the immunomodulator organotellurium compound ammonium trichloro(dioxoethylene-O,O')tellurate (AS101).

Authors:  M Pilar Vázquez-Tato; Alberto Mena-Menéndez; Xesús Feás; Julio A Seijas
Journal:  Int J Mol Sci       Date:  2014-02-21       Impact factor: 5.923

3.  Synthetic organotelluride compounds induce the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisiae.

Authors:  Leandro Figueira Reis de Sá; Fabiano Travanca Toledo; Bruno Artur de Sousa; Augusto César Gonçalves; Ana Claudia Tessis; Edison P Wendler; João V Comasseto; Alcindo A Dos Santos; Antonio Ferreira-Pereira
Journal:  BMC Microbiol       Date:  2014-07-26       Impact factor: 3.605

4.  Synthesis of novel E-2-chlorovinyltellurium compounds based on the stereospecific anti-addition of tellurium tetrachloride to acetylene.

Authors:  Maria V Musalova; Vladimir A Potapov; Svetlana V Amosova
Journal:  Molecules       Date:  2012-05-15       Impact factor: 4.411

5.  Synthesis of Tellurium Oxide (TeO2) Nanorods and Nanoflakes and Evaluation of Its Efficacy Against Leishmania major In Vitro and In Vivo.

Authors:  Pooya Tavakoli; Fatemeh Ghaffarifar; Hamid Delavari; Amir KarimiPourSaryazdi; Mohammad Saaid Dayer; Vahid Nasiri; Salimeh Ahmadi
Journal:  Acta Parasitol       Date:  2021-06-26       Impact factor: 1.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.